Next-Level Therapies for Chronic Venous Insufficiency
We’re developing novel endovenous devices that are safe, easy to use, and cost-effective.
Restoring Health One Vein at a Time
With extensive experience in interventional device manufacturing and commercialization, our seasoned team is creating next-generation endovascular therapies for chronic venous insufficiency (CVI), a progressive medical condition that affects approximately 10% of the adult population.
Target Market
Largely under-diagnosed, CVI affects approximately 10% of the adult population and worsens over time.
Learn More
Our Technology
We’re developing cost-effective devices for CVI that are easy to use and clinically effective.
Learn More
Meet the Team
Our seasoned team has deep domain expertise with interventional cardiovascular therapies.
Learn More